- Home
- SAP vs ABBV Comparison
SAP vs ABBV Comparison
Compare SAP & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAP
- ABBV
- Stock Information
- Founded
- SAP 1972
- ABBV 2012
- Country
- SAP Germany
- ABBV United States
- Employees
- SAP N/A
- ABBV N/A
- Industry
- SAP Computer Software: Prepackaged Software
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- SAP Technology
- ABBV Health Care
- Exchange
- SAP Nasdaq
- ABBV Nasdaq
- Market Cap
- SAP 302.3B
- ABBV 312.8B
- IPO Year
- SAP 1998
- ABBV N/A
- Fundamental
- Price
- SAP $277.96
- ABBV $186.17
- Analyst Decision
- SAP Buy
- ABBV Buy
- Analyst Count
- SAP 6
- ABBV 22
- Target Price
- SAP $282.40
- ABBV $211.81
- AVG Volume (30 Days)
- SAP 1.9M
- ABBV 9.7M
- Earning Date
- SAP 04-22-2025
- ABBV 04-25-2025
- Dividend Yield
- SAP 0.66%
- ABBV 3.53%
- EPS Growth
- SAP 18.35
- ABBV N/A
- EPS
- SAP 5.24
- ABBV 2.34
- Revenue
- SAP $37,988,543,005.00
- ABBV $57,367,000,000.00
- Revenue This Year
- SAP $11.99
- ABBV $7.79
- Revenue Next Year
- SAP $11.97
- ABBV $7.92
- P/E Ratio
- SAP $53.04
- ABBV $79.52
- Revenue Growth
- SAP 10.50
- ABBV 5.45
- 52 Week Low
- SAP $179.15
- ABBV $153.58
- 52 Week High
- SAP $293.70
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- SAP 60.45
- ABBV 49.41
- Support Level
- SAP $269.90
- ABBV $168.54
- Resistance Level
- SAP $277.98
- ABBV $180.50
- Average True Range (ATR)
- SAP 8.60
- ABBV 7.87
- MACD
- SAP 2.72
- ABBV 0.79
- Stochastic Oscillator
- SAP 96.68
- ABBV 90.75
About SAP SAP SE ADS
Founded in Germany in 1972 by former IBM employees, SAP is the world's largest provider of enterprise application software. Known as the leader in enterprise resource planning software, SAP's portfolio also includes software for supply chain management, procurement, travel and expense management, and customer relationship management, among others. The company operates in more than 180 countries and has more than 400,000 customers, approximately 80% of which are small to medium-size enterprises.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).